CanniMed $CMED Receives License from Health Canada to Produce Medical Cannabis Capsules

(TSX: CMED) CanniMed Therapeutics Inc. has initiated production of CanniMed® Capsules, following the receipt of the Production License granted by Health Canada. Subject to Health Canada’s issuance of the required license to sell, CanniMed anticipates the Capsules will be available for patient order … [Read more...]

InMed $IN Names Mauro Maccarrone to Advisory Board

(CSE: IN; OTCQB: IMLFF) InMed Pharmaceuticals Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Mauro Maccarrone is Professor … [Read more...]

Blue Ocean to include Cannabinoids as ingredient

BlueOcean NutraSciences Inc. ("BlueOcean" or the "Company") (TSX-V: BOC) is pleased to announce that it has begun the development of a formulation of hemp extract containing cannabinoids (not including the psychoactive drug THC) in combination with its signature Omega-3 Astaxanthin oil from natural … [Read more...]